NIDA NewsScan #67
August 5th, 2010
To coincide with the 2010 International AIDS Conference in Vienna, NIDA has written a special issue of NewsScan on HIV/AIDS which features recent articles on the connection between drug abuse and HIV/AIDS and prevention and treatment strategies, authored by researchers supported by NIDA and other leading research organizations.
Related posts:
- NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
- Medicare, Common Mechanisms of Drug Abuse and Obesity Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health....
- MedicareCard.com, Meeting Announcement, The NIMH Annual International Research Conference, Role of Families in Preventing and Adapting to HIV/AIDS The NIMH Annual International Research Conference on the Role of Families in Preventing and Adapting to HIV/AIDS is a three-day conference addressing the importance of family in the fight against HIV/AIDS....
- HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published […]...
- Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....
- MedicarCard.com Update – NIH Study Offers Hope to Patients with Nonalcoholic Steatohepatitis A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health...
- MedicareCard.com Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina....
- Medicare Card, Stroke Prevention Study, Children with Sickle Cell Anemia, Iron Overload Stopped Early The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment....
- Medicare Card: NIH-Supported Experimental Marburg Vaccine Prevents Disease Two Days after Infection An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate....
- NIH-Supported ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans....
- MedicareCard.com – Meeting Announcement, Careers in Global Mental Health The NIMH Office for Research on Disparities & Global Mental Health invites qualified and early career professionals to the Careers in Global Mental Health meeting on July 30, 2010....
- MedicareCard.com – NIH Announces Ten Awards for Centers for Population Health and Health Disparities The National Institutes of Health announced today the awarding of 10 new Centers for Population Health and Health Disparities, designed to better understand and address inequities associated with the two leading causes of death in the United States — cancer and heart disease....
- National Institute of Allergy and Infectious Diseases National Institutes of Health on Results from the CAPRISA 004 Microbicide HIV Prevention Study Today we congratulate the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole....
- Medicare Card – Traditional ‘Heel Stick’ Test Is Not an Effective Screening Tool for CMV in Newborns A routine screening test for several metabolic and genetic disorders in newborns, the heel-stick procedure, is not effective in screening for cytomegalovirus (CMV)...
- Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. Due to these events, […]...